Evaluating of VDR gene variation and its interaction with immune regulatory molecules in osteoporosis

Iranian Journal of Public Health

Volumn 38, Issue 2, 2009, Pages 27-36

  Hossein Nezhad, A ^a,b   Ahangari, Gh ^a   Larijani, B ^b  

^a National Institute for Genetic Engineering   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Gene expression; Polymorphism; Vitamin D receptor

Indexed keywords

EID: 68649096144     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. NIH (2001). Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA, 285 (6): 785-95.
2. Chesnut CH, Rose CJ (2001). Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res, 16 (12): 2163-72.
3. Eisman JA (1999). Genetics of osteoporosis. Endocr Rev, 20(6): 788-804.
4. Ferrari S, Rizzoli R, Slosman D, Bonjour JP (1998). Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab, 83(2): 358-61.
5. Ferrari SL, Rizzoli R (2005). Gene variants for osteoporosis and their pleiotropic effects in aging. Mol Aspects Med, 26(3): 145-67.
6. Garnero P, Delmas PD (1998). Biochemical markers of bone turnover: Applications for osteoporosis. Endocrinol Metab Clin North Am, 27 (2): 303-23.
7. Fang Y, Rivadeneira F, Meurs JBJ, Pols HAP, Ioannidis PA, Uitterlinden AG (2006). Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: A meta-analysis. Bone, 39(4): 938-45.
8. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998). The nuclear Vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res, 13(3): 325-49.
9. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996). The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res, 11(12): 1850-55.
10. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994). Prediction of bone density from vitamin D receptor alleles. Nature, 367: 284-87.
11. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999). Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev, 20: 345-57.
12. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000). Inhibition of osteoblasts differentiation by tumor necrosis factor-α. Endocrinology, 141: 3956-64.
13. Canalis E (1986). Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology, 118: 74-81.
14. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD (1987). Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Miner Res, 2: 559-65.
15. Centrella M, McCarthy TL, Canalis E (1988). Tumor necrosis factor-α inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblastenriched bone cell cultures. Endocrinology, 123:1442-48.
16. Smith DD, Gowen M, Mundy GR (1987). Effects of interferon-γ and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology, 120: 2494-99.
17. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K (1997). Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun, 234:137-42.
18. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89: 309-19.
19. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Ieromi Y, Morita K, Morita K (1997). Vitamin D receptor gene polymorphism in the translation initiation codon: effect of protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res, 12: 915-21.
20. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D (1997). The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res, 12: 1043-48.
21. Gennari L, Becherini L, Mansani R, Masi L, Falchetti A, Morelli A, Colli E, Gonnelli S (1999). FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res, 14(8): 1379-86.
22. Choi YM, Jun JK, Hwang JCD, Park SH (2000). Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women. J Hum Genet, 45: 280-83.
23. Kanan RM, Varanasi SS, Francis RM, Parker L, Datta HK (2000). Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol, 53: 93-98.
24. Chen HY, Chen WH, Hsu CD, Tsai FJ, Tsai CH (2002). Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurance of osteoporosis in postmenopausal women in Taiwan. Acta Obstet Gynecol Scand, 81: 93-98.
25. Katsumata K, Nishizawa K, Unno A, Fujita Y, Tokita A (2002). Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Metab, 20: 164-69.
26. Strandberg S, Nordström P, Lorenzon R, Lorenzon M (2003). Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab, 21: 109-13.
27. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1997). Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res, 12 (11): 1761-68.
28. Zmuda JM, Cauley JA, Danielson ME, Ferrell RE (2003). Vitamin D receptor and aromatase gene interaction and bone mass in older African-American women. Metabolism, 52 (5): 521-23.
29. Haynes EN, Kalkwarf HJ, Hornung R, Wenstrup R, Dietrich K, Lanphear BP (2003). Vitamin D Receptor Fok1 Polymorphism and Blood Lead Concentration in Children. Environ Health Perspect, 111(13): 1665-9.
30. Nieves JW, Ralston SH, Vásquez E, Ambrose B, Cosman F (2007). Vitamin D receptor Fok1 polymorphism influences response to vitamin D supplementation in postmenopausal African-American women. International Congress Series, 1297: 126-32.
31. Laaksonen MML, Kärkkäinen MUM, Outila TA, Rita HJ, Lamberg-Allardt CJE (2004). Vitamin D receptor gene start codon polymorphism (FokI) is associated with forearm bone mineral density and calcaneal ultrasound in Finnish adolescent boys but not in girls. J Bone Miner Metab, 22: 479-85.
32. Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP (1998). Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms. J Bone Miner Res, 13(6): 925-30.
33. Zofkova I.I, Zajickova K, Hill M (2003). Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women, Eur J Intern Med, 14(4): 232-36.
34. Puchacz E, Lian J.B, Stein G.S, Wozney J, Huebner K, Croce C (1989). Chromosomal localization of the human osteocalcin gene. Endocrinology, 124: 2648-50.
35. Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA(1991). Genetic factors in bone turnover. J Clin Endocrinol Metab, 72: 808-13.
36. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN (1987). Genetic determinants of bone mass in adults: a twin study. J Clin Invest, 80: 706-10.
37. Ihnatko R, Kubes M (2007).TNF signaling: early events and phosphorylation. Gen Physiol Biophys, 26(3):159-67.
38. Fontova R, Gutiérrez C, Vendrell J, Broch M, Vendrell I, Simón I, Fernández-Real JM, Richart C (2002). Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women. J Endocrinol Invest, 25(8): 684-90.
39. Gianni W, Ricci A, Gazzaniga P, Brama M, Pietropaolo M, Votano S, Patane F, Agliano AM, Spera G (2004). Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study. J Clin Endocrinol Metab, 89: 6097-99.
40. Tsoukas CD, Watry D, Escobar SS, Provvedini DM, Dinarello CA, Hustmyer FG, Manolagas SC (1989). Inhibition of interleukin-1 production by 1, 25-dihydroxy-vitamin D3. J Clin Endocrinol Metab, 69(1): 127-33.
41. Baldock PA, Thomas GP, Hodge JM, Baker SU, Dressel U, O'Loughlin PD, Nicholson GC, Briffa KH, Eisman JA, Gardiner EM (2006). Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res, 21(10): 1618-26.